Advice about ALL treatment in the clinical setting
In this interview, Torsten Haferlach, MD, of MLL Munich Leukemia Laboratory, Munich, Germany, reflects on the differences between the treatment of acute lymphoblastic leukemia (ALL) in clinical practi...
Author: VJHemOnc
Added: 08/16/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer & Oncology | Germany Health | Laboratory Medicine | Leukemia